Stifel Reiterates Buy Rating on Biogen (BIIB)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
Go back to Stifel Reiterates Buy Rating on Biogen (BIIB)
June 5, 2024 9:00 PM EDT
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Biogen Inc. (NASDAQ: BIIB), Charge Enterprises (NASDAQ: CRGEQ), and Fastly, Inc. (NYSE: FSLY). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Biogen Inc. (NASDAQ: BIIB)
...
More
June 5, 2024 3:26 PM EDT
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq: BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases/biogen-inc-investigation.... More
June 4, 2024 1:45 AM EDT
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
Do you, or did you, own shares of Biogen Inc. (NASDAQ:
BIIB)?
Did you purchase your shares between February 3, 2022 and February 13, 2024, inclusive?
Did you lose money in your investment in Biogen Inc.?
Do you want to discuss your rights?
Bernstein Liebhard LLP... More
